There is currently no cure for dementia, which afflicts an estimated 57 million people globally, and affects hundreds of millions more who are the family, friends, and caretakers of people with ...

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

More than $100 million in federal funding was spent last year toward searching for a cure for Alzheimer's disease. However, if given the choice, most people with dementia and those caring for them ...

When Jill Lorentz was in her 20s, she said her mother started showing signs of forgetfulness. “As we got a little bit older, she started having mild memory loss and we didn’t think anything of it ...

A major study involving over 160,000 dementia patients has found that risperidone, a commonly prescribed antipsychotic drug, is associated with higher stroke risk across all dementia patient groups ...

Memory loss might have met its match. A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing ...

Families can help loved ones live well after a dementia diagnosis by planning early, creating a safe environment, staying engaged in meaningful activities, and building a strong support network ...

A bill making its way through the Nebraska Legislature would require state-regulated health plans to cover US Food and Drug Administration-approved dementia treatments and diagnostics as well as ...

A major new study finds people with type 1 diabetes face nearly three times the dementia risk. But lifestyle changes and new treatments offer real hope.

Add Yahoo as a preferred source to see more of our stories on Google. Oct. 9—A proposition on the Nov. 4 ballot, if approved by voters, could make access to dementia treatment and innovation easier ...

A terrible irony of dementia — which can result in the inability to recognize people and places — is that the condition itself does not get the worldwide recognition it deserves. Until now. The United ...